Ethical, Social, and Economic Challenges in Managing a Child with Dravet Syndrome in a Developing CountryFunding None.
Epilepsy is a chronic neurological disorder with a significant impact on sociocultural and economic aspects. The management of epilepsy in low-middle income countries (LMICs) is influenced by many factors such as disease burden, poverty, educational status, the reflection of the disease as a social stigma, diverse religious beliefs, and treatment expense. Despite the improvement in educational and social parameters, the stigmatization of the disease is still evident in many LMICs. The associated comorbidities and neurodevelopmental disorders further add to the cost and stigmatization. The pediatric neurologists/epileptologists in LMICs are encountered by distinctive ethical, social, and economic dilemmas during the patient care and management of epilepsy. This article discusses the various ethical dilemmas in a child with Dravet syndrome in a developing country.
P.M. and R.S. prepared the initial draft of the manuscript and reviewed the literature. S.G. conceptualized the study, took part in initial draft preparation, performed critical review of the manuscript and reviewed the literature, and also edited the final version of the manuscript. All the authors approved the final version of the manuscript.
Received: 02 June 2020
Accepted: 02 June 2020
15 July 2020 (online)
© 2020. Thieme. All rights reserved.
Georg Thieme Verlag KG
Stuttgart · New York
- 1 Das K, Banerjee M, Mondal GP, Devi LG, Singh OP, Mukherjee BB. Evaluation of socio-economic factors causing discontinuation of epilepsy treatment resulting in seizure recurrence: a study in an urban epilepsy clinic in India. Seizure 2007; 16 (07) 601-607
- 2 Joseph N, Kumar GS, Nelliyanil M. Pattern of seizure cases in tertiary care hospitals in Karnataka state of India. Ann Indian Acad Neurol 2013; 16 (03) 347-351
- 3 Satishchandra P, Gururaj G, Mohammed QD, Senanayake N, Silpakit O. Epilepsy: Out of the Shadows: From Prejudice to Hope. New Delhi: World Health Organization, Regional Office for South East Asia; 2001: 42
- 4 O'Callaghan FJK, Lux AL, Darke K. , et al. The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study. Epilepsia 2011; 52 (07) 1359-1364
- 5 Chiron C, Helias M, Kaminska A. , et al. Do children with Dravet syndrome continue to benefit from stiripentol for long through adulthood?. Epilepsia 2018; 59 (09) 1705-1717
- 6 Meinardi H, Scott RA, Reis R, Sander JW. ILAE Commission on the Developing World. The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 2001; 42 (01) 136-149
- 7 Iyer RS, Rekha M, Kumar TS, Sarma PS, Radhakrishnan K. Primary care doctors' management behavior with respect to epilepsy in Kerala, southern India. Epilepsy Behav 2011; 21 (02) 137-142
- 8 Dash D, Sebastian TM, Aggarwal M, Tripathi M. Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy Behav 2015; 44: 213-217
- 9 Gourie-Devi M, Satishchandra P, Gururaj G. Epilepsy control program in India: a district model. Epilepsia 2003; 44 (Suppl. 01) 58-62
- 10 Pal DK, Chaudhury G, Sengupta S, Das T. Social integration of children with epilepsy in rural India. Soc Sci Med 2002; 54 (12) 1867-1874